Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Related
2024 NACDS TSE welcomes NACDS chain and supplier members to Boston
NACDS Leaders: Pharmacy is a catalyst for change and innovation, and NACDS TSE is where it happens.
Walmart says a new era of 'Adaptive Retail' is here
Walmart commissioned Morning Consult to conduct a survey of more than 2,200 U.S. shoppers.
Census data shows modest sales gains in June
WASHINGTON – Data released by the U.S. Census Bureau shows modest retail sales gains in June despite an uneven pace of spending in recent months, National Retail Federation chief economist Jack Kleinhenz said. “The path of household spending remains difficult to read,” Kleinhenz said.
FTI says online retail sales to hit $1.2 Trillion
U.S. online retail sales will reach $1.2 trillion in 2024, up nearly 10% from last year, according to FTI Consulting’s 2024 Online Retail Report. The firm’s Retail & Consumer Products practice, which conducted analysis for the report, expects U.S. e-commerce sales to account for 22.
Latest
Emarketer: TikTok's share of U.S. social commerce nears 20%
A fast-growing subsector of e-commerce.
RILA and Optera release DPED v2 to enhance product emissions transparency
Updates enable retailers and industry leaders to more accurately and consistently measure and communicate direct-use product emissions.
Mars to finalize Kellanova acquisition this week
Mars gets final approval for kellanova acquisition, clearing the path for the industry’s biggest packaged-food merger in ten years.